Animal Welfare Information Center News Feed


The Animal Welfare Information Center News Feed pulls together news items related to animal health, behavior and welfare. It also provides information on new AWIC publications and changes to the AWIC Web site.



Animal Testing (EURL ECVAM) in conducting a survey to identify in vitro human hepatic metabolic clearance/stability methods that can contribute to the development of harmonized standards and associated international test guidelines.
Thursday, April 17, 2014 - 07:30
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)

NICEATM AND COLLABORATORS PUBLISH OPEN-SOURCE INTEGRATED TESTING STRATEGY FOR SKIN SENSITIZATION POTENCY

In a recent short communication to the journal ALTEX, NICEATM scientists and collaborators describe an open-source implementation of a previously published integrated testing strategy (ITS) for skin sensitization. The ITS uses a Bayesian network to provide probabilistic predictions of skin sensitization potency based on in silico and in vitro information as well as skin penetration characteristics. The Bayesian network was designed to be consistent with the adverse outcome pathway published by the OECD.

The short communication is available at http://www.altex.ch/resources/Pirone_of_20140331.pdf. The data used to develop the ITS and a fully documented version of the R code for the ITS are available at http://ntp.niehs.nih.gov/go/its.

EURL ECVAM SURVEY ON IN VITRO METHODS FOR ESTIMATING HUMAN HEPATIC METABOLISM

Hepatic metabolic clearance plays a key role in the transformation and the elimination of chemicals from the human body, and in vitro methods for human hepatic metabolic clearance/stability are being developed. The European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) in conducting a survey to identify in vitro human hepatic metabolic clearance/stability methods that can contribute to the development of harmonized standards and associated international test guidelines.

The survey will be available until June 30 at http://ihcp.jrc.ec.europa.eu/our_labs/eurl-ecvam/eu-netval/in-vitro-methods-survey-March-2014.

UPCOMING MEETINGS AND WORKSHOPS

FDA will convene a workshop on "Methods for Thrombogenicity Testing of Medical Devices" on April 14 at the FDA White Oak Campus in Silver Spring, MD. Participants will discuss optimizing the conduct of the current in vivo 4-hour canine thrombogenicity test and identification of alternative in vitro tests that could provide equivalent or improved clinical insight. Advance registration for the workshop is closed, but onsite registration will be available the day of the workshop on a first-come, first-served basis. More information and pre-workshop reference materials are available at http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm387409.htm.

NICEATM and North Carolina State University (NCSU) are presenting a "Collaborative Workshop on Aquatic Models and 21st Century Toxicology" May 5-6 at the Hunt Library at NCSU in Raleigh, NC. The purpose of the workshop will be to explore and discuss how aquatic models may be used to (i) screen and prioritize compounds for further in vivo testing and (ii) assess mechanisms of chemical toxicity and how this knowledge can impact the environment and human health. The workshop will include a poster session and abstracts are currently being accepted; trainee travel awards are also available. Information about the workshop and a link to registration is available at http://ntp.niehs.nih.gov/go/41308.

The Ninth World Congress on Alternatives and Animal Use in the Life Sciences will be held August 24-28 in Prague, Czech Republic. Abstracts for poster and platform presentations are currently being accepted: the submission deadline is April 15. More information is available at http://www.wc9prague.org.

NICEATM, EURL ECVAM, and the Physicians Committee for Responsible Medicine are presenting a workshop on "Adverse Outcome Pathways: From Research to Regulation" September 3-5 in the William H. Natcher Conference Center, National Institutes of Health, Bethesda, MD. Information for this workshop is available at http://ntp.niehs.nih.gov/go/41374; a registration form will be available on this page in the near future.


Tuesday, April 8, 2014 - 10:51
DHSS. NIH. Office of Laboratory Animal Welfare.

Visit the Guidance section on the Office of Laboratory Animal Welfare, OLAW, website for updated Commentary on Lab Animal Protocol Review columns. “A word from USDA and OLAW” responds to the topic “Using privately owned animals in a study of human subjects” in the April 2014 issue.


Monday, April 7, 2014 - 09:40
USDA. ARS. NAL. Animal Welfare Information Center.

Thursday, March 27, 2014 - 15:06
FDA. Center for Veterinary Medicine.

Scientists at the Food and Drug Administration (FDA) who work in veterinary medicine are dedicated to keeping animals, including pets and farm animals, healthy. And they have found that when it comes to research, there is strength in numbers.


Thursday, March 27, 2014 - 15:03
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)

The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) will hold a public meeting at the National Institutes of Health Natcher Conference Center in Bethesda, MD, the afternoon of Wednesday, June 25, 2014. The purpose of this public meeting is to communicate progress on topics of interest to ICCVAM stakeholders and provide stakeholders with an opportunity to comment and ask questions.

The meeting will be open to the public with attendance limited only by the space available. Details of the meeting, including exact times, options for remote participation, and information for prospective attendees and presenters, will be published in the Federal Register, posted on the NTP website, and distributed via this email list in late April.


Tuesday, March 25, 2014 - 17:44
HHS. FDA. Center for Veterinary Medicine.

Since 2007, FDA has received reports of illnesses in pets associated with the consumption of jerky pet treats. As of September 24, 2013, FDA has received approximately 3000 reports of pet illnesses which may be related to consumption of the jerky treats. The reports involve more than 3600 dogs, 10 cats and include more than 580 deaths.


Monday, March 24, 2014 - 08:41
USDA. APHIS. Veterinary Services.

INFORM: Veterinary Services Training and Exercise Strategy (VS T&E) Plan FY 2014-2016

USDA Animal and Plant Health Inspection Service sent this bulletin at 03/21/2014 10:48 AM EDT
USDA APHIS Veterinary Services recently announced in the VS Bulletin 2014.01 (linked below) that the Veterinary Services Training and Exercise Strategy (VS T&E) Plan (linked below) is now available for fiscal years 2014 to 2016.

You may contact Dr. Lee Myers at Lee.M.Myers@aphis.usda.gov or Dr. Paula Cowen at Paula.L.Cowen@aphis.usda.gov with any questions.

***
Please share the following link with others who may be interested in these updates. Click here to subscribe to the VS Animal Health Stakeholder Registry. This link will also allow you to change or cancel your subscriptions.
VS_Training_and_Exercise_Plan_document.pdf
VSB 2014 01 Availability of VS Training and Exercise Plan _Final.pdf


NICEATM and ICCVAM Activites Next Week at SOT
Monday, March 24, 2014 - 07:57
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)

The Annual Meeting of the Society of Toxicology will take place March 23-27 at the Phoenix Convention Center in Phoenix, Arizona. NICEATM and ICCVAM activities at SOT will include:

-- A Continuing Education Course on Elucidating Adverse Outcome Pathways for Developmental Toxicity, at which ILS NICEATM contract staff member Dr. Nicole Kleinstreuer will be presenting

-- A session on non-animal approaches to photosafety testing of pharmaceuticals co-chaired by ICCVAM member Dr. Abby Jacobs of the FDA's Center for Drug Evaluation and Research

-- A poster describing NLM's toxicology education resources presented by ICCVAM member Dr. Pertti (Bert) Hakkinen of the National Library of Medicine

-- Fourteen posters on NICEATM activities in sessions including Alternatives to Mammalian Models, Computational Toxicology and Data Integration, and Risk Assessment, with authors including NICEATM Director Dr. Warren Casey and eight members of the ILS NICEATM contract staff.

Information on NICEATM and ICCVAM activities at SOT is available at http://ntp.niehs.nih.gov/go/41297.

SOT ANCILLARY MEETINGS ON ADVERSE OUTCOME PATHWAYS

In addition to the SOT Continuing Education Course, ancillary meetings at SOT will focus on Adverse Outcome Pathways and related topics. Please contact Kristie Sullivan at ksullivan@pcrm.org or Catherine Willett at kwillett@humanesociety.org for more information about these meetings.

--Three "Stakeholder Input Sessions" to support development of a knowledge base for quantitative modeling of AOPs will be held during SOT. These three interactive, participatory sessions are intended to elicit stakeholder input on the required characteristics of tools currently being developed to capture and model quantitative elements of Adverse Outcome Pathways in a visual, “wiki” platform. Attendees from all sectors and with all levels of experience with AOPs are welcome. The sessions at the Hyatt Regency Phoenix will be held at:

Monday, March 24, 5:00 – 6:30 pm, Borein Room
Tuesday, March 25, 12:00 – 1:30 pm, Cassidy Room
Thursday, March 27, 8:00 – 9:00 am, Remington Room

--A workshop on "AOPs 101: The How and Why of Development and Use" will be held from 5:00-7:00 PM on Monday, March 24, in Regency Ballroom A at the Hyatt Regency Phoenix. U.S. and European speakers from industry, academia, and government will provide an introduction to AOPs and some examples of their development and use.

--A workshop covering "Updates on 21st Century Activities and Related Efforts" will be held from 12:30-4:00 PM on Thursday, March 27, in the Deer Valley Room at the Sheraton Phoenix Downtown. Seven U.S. and European speakers will give updates on high-throughput screening and evidence-based toxicology projects. The scheduled presentations will be followed by a 1-hour "open mic" session for additional presentations and discussion. Registration is requested for this workshop: please contact Jamie DeRita at jderita@jhsph.edu.

BEYOND SOT: UPCOMING 3RS WORKSHOPS

FDA will convene a workshop on "Methods for Thrombogenicity Testing of Medical Devices" on April 14 at the FDA White Oak Campus in Silver Spring, MD. Participants will discuss optimizing the conduct of the current in vivo 4-hour canine thrombogenicity test and identification of alternative in vitro tests that could provide equivalent or improved clinical insight. Register for the workshop or find more information at http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm387409.htm.

EPA is holding two meetings this spring on its ToxCast program.
--A ToxCast Stakeholder Workshop to request stakeholder feedback on the new Toxicity Forecaster (ToxCast) chemical screening data will be held in Washington, DC, on April 2-3. Information on the Stakeholder Workshop is available at https://sites.google.com/site/toxcastworkshopdc/home.
--The Second ToxCast Data Summit will present findings on the most promising analytical strategies for developing methods to predict whole animal or human chemical toxicity from in vitro data. The ToxCast Data Summit will be held May 14-15 in Research Triangle Park, NC; information is available at https://sites.google.com/site/toxcastdatasummit/.

A "Collaborative Workshop on Aquatic Models and 21st Century Toxicology" will be held May 5-6 at the Hunt Library at North Carolina State University in Raleigh, NC. The purpose of the workshop will be to explore and discuss how aquatic models may be used to (i) screen and prioritize compounds for further in vivo testing and (ii) assess mechanisms of chemical toxicity and how this knowledge can impact the environment and human health. The workshop will include a poster session and abstracts are currently being accepted; trainee travel awards are also available. Information about the workshop and a link to registration is available at http://ntp.niehs.nih.gov/go/41308.

A workshop on "Adverse Outcome Pathways: From Research to Regulation" will be held September 3-5 in the William H. Natcher Conference Center, National Institutes of Health, Bethesda, MD. Information and registration forms for this workshop will be available on the NTP website in the near future.


Update of EPA EDSP Comprehensive Management Plan, Upcoming Workshops
Wednesday, March 19, 2014 - 14:43
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)

EPA UPDATES EDSP COMPREHENSIVE MANAGEMENT PLAN

The EPA has updated its Endocrine Disruptor Screening Program (EDSP) Comprehensive Management Plan to emphasize the utilization of advanced informational technology and computational methods. The mission of the EDSP is to protect people, wildlife and our environment from chemicals that adversely affect endocrine systems by screening pesticides, chemicals and environmental contaminants for their potential effects on estrogen, androgen and thyroid hormone systems. The updated 2014 EDSP Comprehensive Management Plan provides strategic guidance for agency personnel and outlines the critical EDSP activities that are planned for this program over the next five years. Among the many critical activities is a core focus on using informational technology to enhance data interpretation and applying computational methods to more efficiently prioritize and screen the universe of EDSP chemicals for potential effects on the endocrine system. This document is made available to the public a s a source of information and to ensure open transparency. Detailed information is available at http://www.epa.gov/endo/.

UPCOMING CONFERENCES AND WORKSHOPS

FDA will convene a workshop on "Methods for Thrombogenicity Testing of Medical Devices" on April 14 at the FDA White Oak Campus in Silver Spring, MD. Participants will discuss optimizing the conduct of the current in vivo 4-hour canine thrombogenicity test and identification of alternative in vitro tests that could provide equivalent or improved clinical insight. Register for the workshop or find more information at http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm3874.

EPA is holding two meetings this spring on its ToxCast program.
--A ToxCast Stakeholder Workshop to request stakeholder feedback on the new Toxicity Forecaster (ToxCast) chemical screening data will be held in Washington, DC, on April 2-3. Information on the Stakeholder Workshop is available athttps://sites.google.com/site/toxcastworkshopdc/home.
--The Second ToxCast Data Summit will present findings on the most promising analytical strategies for developing methods to predict whole animal or human chemical toxicity from in vitro data. The ToxCast Data Summit will be held May 14-15 in Research Triangle Park, NC; information is available at https://sites.google.com/site/toxcastdatasummit/.

A "Collaborative Workshop on Aquatic Models and 21st Century Toxicology" will be held May 5-6 at the Hunt Library at North Carolina State University in Raleigh, NC. The purpose of the workshop will be to explore and discuss how aquatic models may be used to (i) screen and prioritize compounds for further in vivo testing and (ii) assess mechanisms of chemical toxicity and how this knowledge can impact the environment and human health. The workshop will include a poster session and abstracts are currently being accepted; trainee travel awards are also available. Information about the workshop and a link to registration is available at http://ntp.niehs.nih.gov/go/41308.

A workshop on "Adverse Outcome Pathways: From Research to Regulation" will be held September 3-5 in the William H. Natcher Conference Center, National Institutes of Health, Bethesda, MD. Information and registration forms for this workshop will be available on the NTP website in the near future.

--
Catherine Sprankle
Sr. Communications Specialist
Integrated Laboratory Systems, Inc./Contractor supporting the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods National Institute of Environmental Health Sciences MD K2-16, P.O. BOX 12233 Research Triangle Park, NC 27709
Phone: (919) 544-5857 ext. 241
Email: spranklec@niehs.nih.gov
Website: http://ntp.niehs.nih.gov/go/niceatm


Thursday, March 13, 2014 - 13:31
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)

OPEN-SOURCE INTEGRATED TESTING STRATEGY TO IDENTIFY POTENTIAL SENSITIZERS

NTP scientists are collaborating with Dr. Joanna Jaworska and colleagues at Procter and Gamble, who developed an integrated testing strategy for identifying potential skin sensitizers without conducting animal tests. The testing strategy uses a Bayesian network to analyze data from non-animal tests and other information about a test substance, such as chemical structure and solubility, to identify potential skin sensitizers. The software used by Procter and Gamble for these analyses is patented. Thus, the goal of the current project is to develop similar tools using open-source software to make the integrated testing strategy approach more widely available so that organizations worldwide may use this approach for identifying potential sensitizers.

Files for running the open-source integrated testing strategy analysis are available on the NTP website at http://ntp.niehs.nih.gov/go/its. Users of these files are strongly encouraged to join a listserv that has been established for users to provide feedback and share results. To join the listserv, go to https://list.nih.gov/cgi-bin/wa.exe?SUBED1=ITS-OS-COMM&X=2889916917F32E8157-4F8749712A4C1A9EBD33714E3C5A8AEF-LUI1387833694312.

MURINE LOCAL LYMPH NODE ASSAY LITERATURE DATABASE NOW AVAILABLE

On behalf of ICCVAM, NICEATM has conducted a number of analyses to evaluate the usefulness of the murine local lymph node assay (LLNA) to identify potential skin sensitizers. NICEATM is making this data available for reference to interested stakeholders for developing and evaluating alternative methods that replace, reduce, or refine the use of animals for skin sensitization testing. The database is available on the NTP website at http://ntp.niehs.nih.gov/go/40498.


Thursday, March 13, 2014 - 13:24
HHS. FDA. Center for Veterinary Medicine.

The U.S. Food and Drug Administration announced today an opportunity for public comment on FDA’s proposed collection of information from sponsors of generic animal drugs.


Thursday, March 13, 2014 - 13:24
USDA. APHIS. Veterinary Services.

Notice 13-10, Changes to the Rabies Virus NIH Potency Test Validity Requirements, has been recently added to the Center for Veterinary Biologics (CVB) Web site and is available at: http://www.aphis.usda.gov/animal_health/vet_biologics/publications/notice_13_10.pdf.

CVB Notice 13-10, signed July 26, 2013, informs licensees, permittees, and applicants of the CVB’s intent to eliminate the median lethal dose (LD50) upper limit for the challenge virus as a validity requirement when conducting the Rabies Virus NIH potency test.

For a valid challenge, the LD50 is now greater than or equal to 12. Supplemental Assay Method 308 will be amended to reflect this change, which is effective immediately.


Thursday, March 13, 2014 - 13:22
USDA. APHIS. Animal Care.

The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) is continuing to move swiftly and consistently to take enforcement action in response to animal welfare violations. As part of its effort to make its actions transparent and accessible to the public, APHIS is highlighting enforcement actions taken in response to violations of the Animal Welfare Act (AWA) and Horse Protection Act (HPA).


Thursday, March 13, 2014 - 09:31
USDA. APHIS. Wildlife Services.

Taking on an adult grizzly bear or a pack of wolves is a lot to ask of a livestock protection dog, but it’s a task they willingly take to protect their herds from predation. For centuries, livestock protection dogs have helped ranchers protect livestock from coyotes, feral dogs, foxes, and mountain lions. Without them, thousands of sheep, lambs, and calves would be killed or injured each year.

http://content.govdelivery.com/accounts/USDAAPHIS/bulletins/a7b7ed


Thursday, March 13, 2014 - 09:27
USDA. APHIS. Animal Care.

USDA Animal Care has revised its factsheet entitled Questions and Answers: Regulation of Dog/Cat Breeders and Dealers.

This factsheet provides information that we hope you find useful, including: 1) the types of dog/cat breeders and dealers regulated under the Animal Welfare Act; 2) the standards of care required by USDA; and 3) USDA’s role in the commercial transport of dogs/cats.

http://www.aphis.usda.gov/publications/animal_welfare/content/printable_version/faq_animal_dealers.pdf


Thursday, March 13, 2014 - 09:26
USDA. APHIS. Animal Care.

USDA Animal Care has created a publication entitled Proper Giraffe Care in Cold Weather.

This tech note provides information that we hope will aid in the care and treatment of giraffes. These animals are highly susceptible to cold temperatures because they do not acclimate to the cold as effectively as most other mammals.

http://www.aphis.usda.gov/animal_welfare/content/printable_version/tech%20note%20-%20giraffes%20in%20the%20cold.pdf


A New Vision and Direction for ICCVAM: Comments Requested on Draft Document
Thursday, March 13, 2014 - 09:24
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)

The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) work together to promote the development, validation, and regulatory acceptance of new and revised regulatory test methods. In a February 2013 editorial in the journal Environmental Health Perspectives, National Institute of Environmental Health Sciences and NTP Director Linda Birnbaum announced upcoming significant changes to the focus and priorities of both ICCVAM and NICEATM.

A draft document now available on the NTP website, titled “A New Vision and Direction for ICCVAM,” describes the initial steps towards a new strategic direction for ICCVAM. Specifically, this document discusses (1) ICCVAM priority setting and areas for scientific focus for immediate resource investment; (2) plans to improve communications with stakeholders and the public; and (3) exploration of new paradigms for the validation and utilization of alternative toxicological methods.

NICEATM invites public comments on “A New Vision and Direction for ICCVAM.” The document will be discussed at the Sept. 24 meeting of the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM).

Links to “A New Vision and Direction for ICCVAM,” the Environmental Health Perspectives editorial, and the ICCVAM response to the editorial are available on the SACATM Background Materials page http://ntp.niehs.nih.gov/go/40529, under the heading “New ICCVAM Vision and Procedures.” To submit a comment on “A New Vision and Direction for ICCVAM,” go to http://ntp.niehs.nih.gov/go/opensolicitations and select the “Submit Comment” link beside the SACATM meeting announcement. Written comments submitted by September 10 will be considered during the discussion of the draft document at the SACATM meeting.

For more information about the SACATM meeting, go to http://ntp.niehs.nih.gov/go/32822. This page includes links to the Background Materials page, a preliminary meeting agenda, a registration form to attend the meeting, and a webcast that will be available on the day of the meeting.


Grants Available from the Alternatives Research and Development Foundation
Thursday, January 23, 2014 - 14:13
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)

The Alternatives Research and Development Foundation is currently soliciting research proposals for its 2014 Alternatives Research Grant Program. Grants of up to $40,000 are available to support individual projects of scientific merit and feasibility with the potential to significantly reduce or replace laboratory animal use. Preference will be given to projects as U.S. universities and research institutions and projects that use pathway-based approaches.

More information is available on the ARDF website at http://www.ardf-online.org. Application deadline for the grants is April 30, 2014.


Thursday, January 23, 2014 - 14:17
USDA. APHIS. Animal Care.

The Animal Care Information System (ACIS) is the powerful, searchable database created by USDA Animal Care that provides useful information about individuals/facilities regulated under the Animal Welfare Act. This information – including animal inventories, inspection report citations and the number of animals used in medical research – is accessible to one and all via the Animal Care website and is provided in multiple formats to meet peoples’ individual needs as they create their own searches.

At the moment, however, ACIS is not performing optimally. We are faced with technical challenges that are affecting not only the speed with which users can retrieve information from ACIS but also the accuracy and consistency of some of that information. Our technical team is aware of the problems and is working to resolve the issues. We please ask for your patience in this matter.

ACIS has been a valuable resource to thousands of people since its creation in 2011. We will do all we can to correct the current technical issues so that we can once again provide you with accurate, timely information.

At USDA Animal Care, ensuring the welfare of the animals we regulate is at the heart of everything we do.


Thursday, January 23, 2014 - 14:17
USDA. APHIS. Animal Care.

To more efficiently share Horse Protection Act (HPA) information, USDA Animal Care will now use the USDA/APHIS Stakeholder Registry to periodically alert you when we post our disqualification lists and enforcement actions.

The following link will take you to the most recent list of violators who have been disqualified from participating in HPA-regulated horse shows/exhibitions/sales/auctions: http://www.aphis.usda.gov/animal_welfare/hp/downloads/reports/USDAHPDQ_01072014.pdf.

The following link will take you to the USDA news release that includes the most recently completed HPA enforcement cases: http://www.aphis.usda.gov/newsroom/2013/12/awa_november.shtml.

We will continue to do all we can to make the cruel and inhumane practice of soring horses a thing of the past. For more information, please visit our Horse Protection Program webpage: http://www.aphis.usda.gov/animal_welfare/hpa_info.shtml.

At USDA Animal Care, ensuring the welfare of the animals we regulate is at the heart of everything we do.


Thursday, January 23, 2014 - 14:18
USDA. APHIS. Animal Care.

As part of our ongoing efforts to enforce the Horse Protection Act and eliminate the cruel and inhumane practice of soring horses, USDA Animal Care will host a webinar with a renowned expert in the fields of equine thermography and digital imaging.

Dr. Tracy A. Turner, DVM, MS (diplomate, American College of Veterinary Surgeons; diplomate, American Board of Thermology), will present scientific evidence in the form of thermal and digital imaging that he has collected over the past six years while serving as a consultant to USDA’s Horse Protection Program. His advancements in the area of thermography are helping us make strides as we continue to work with the walking horse industry to ensure that only sound and healthy horses participate in shows/exhibitions/sales/auctions.

Dr. Turner, a professionally recognized leader in equine podiatry, has published over 100 manuscripts and book chapters. As an influential member of the American Association of Equine Practitioners, he has served on numerous national and state committees. He attended veterinary school at Colorado State University, interned at the University of Georgia and completed his surgical residency and Master of Science degree at Purdue University. He has held multiple academic positions, including chief of large animal surgery at the University of Minnesota. Dr. Turner is a member of the International Equine Veterinarians Hall of Fame and is one of only four individuals to be board certified in veterinary thermography.

The webinar will take place Friday Jan. 17, 2014, from 3 p.m. to 5 p.m. EST. To register, please click here: https://www4.gotomeeting.com/register/705181247.

We look forward to your attendance and your participation during the webinar.

At USDA Animal Care, ensuring the welfare of the animals we regulate is at the heart of everything we do.


Thursday, January 23, 2014 - 14:19
APHIS Animal Care

With temperatures expected to remain extremely low in many parts of the country, USDA Animal Care urges licensees/registrants with outdoor-housed animals to please take the necessary steps to ensure that your animals are protected from the cold.

Thank you for your prompt attention to this matter. Our goal is the same as yours: ensuring the welfare of your animals.


Updated Animal Welfare Act Regulations Posted on USDA's Animal Care Website
Tuesday, November 5, 2013 - 13:35
USDA. APHIS. Animal Care.

USDA Animal Care has posted the most up-to-date version of the Animal Welfare Act regulations on its website: http://www.aphis.usda.gov/animal_welfare/index.shtml. On this homepage, you will see the familiar “Blue Book” cover on the right side. Clicking on this image will pull up the Animal Welfare Act and its associated regulations.

The Animal Welfare Act and its regulations require that basic standards of care be provided for certain animals used in certain activities – including warm-blooded animals exhibited to the public, bred for commercial sale, used in medical research or transported commercially. We monitor the care of these animals by conducting unannounced inspections of all facilities licensed and registered under the Animal Welfare Act. When regulated facilities abide by these federal standards, we know that their animals are receiving humane care and treatment.


Monday, January 6, 2014 - 09:48
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)

The European Union Reference Laboratory for alternatives to animal testing (EURL ECVAM) is accepting public comments on draft recommendations for two non-animal test methods. The direct
peptide reactivity assay is recommended as a screening test to identify substances with the potential to cause allergic contact dermatitis. The Bhas 42 cell transformation assay is recommended
as a screening test to identify potential carcinogens.

The draft recommendations are available on the European Union Institute for Health and Consumer Protection website . EURL ECVAM is accepting comments on both draft recommendations through September 13. Comments may be submitted by email to JRC-ECVAM-CONTACT@ec.europa.eu.

This announcement was originally distributed via the ICCVAM-all email list.
Subscribing to the ICCVAM-all email list will enable you to be notified directly of NICEATM and ICCVAM activities. Subscribers receive email notification of publication of NICEATM Federal Register notices, availability of ICCVAM reports, notices of upcoming meetings, requests for public comments or data, and other events of interest to our stakeholders.


Thursday, March 20, 2014 - 13:24
USDA. APHIS. Veterinary Services.

Notice 13-10, Changes to the Rabies Virus NIH Potency Test Validity Requirements, has been recently added to the Center for Veterinary Biologics (CVB) Web site and is available at: http://www.aphis.usda.gov/animal_health/vet_biologics/publications/notice_13_10.pdf.

CVB Notice 13-10, signed July 26, 2013, informs licensees, permittees, and applicants of the CVB’s intent to eliminate the median lethal dose (LD50) upper limit for the challenge virus as a validity requirement when conducting the Rabies Virus NIH potency test.

For a valid challenge, the LD50 is now greater than or equal to 12. Supplemental Assay Method 308 will be amended to reflect this change, which is effective immediately.